Sharon Barr
Impact in
- Genetics top 0.5%
- Mesenchymal stem cell research
- Biomaterials top 2%
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 10
- RNA Research and Splicing 2
- Angiogenesis and VEGF in Cancer 2
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Eugenio Stabile (2 shared papers)Stephen E. Epstein (2 shared papers)Mary Susan Burnett (2 shared papers)Timothy Kinnaird (1 shared paper)Sabine Fuchs (1 shared paper)Tim Kinnaird (1 shared paper)Shmuel Fuchs (1 shared paper)Magang Shou (1 shared paper)
- Journals
- Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)Blood (3 papers)Biochemical and Biophysical Research Communications (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Sharon Barr
27 papers receiving 3.5k citations
Sharon Barr's Hit Papers
Peers
Comparison fields: 5 of 93
- Genetics 1.4k
- Biomaterials 467
- Cancer Research 432
- Molecular Biology 1.7k
- Surgery 950
Countries citing papers authored by Sharon Barr
This map shows the geographic impact of Sharon Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Barr more than expected).
Fields of papers citing papers by Sharon Barr
This network shows the impact of papers produced by Sharon Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Barr. The network helps show where Sharon Barr may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharon Barr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms Hit paper breakdown → | 2004 | 1122 |
| 2 | Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms Hit paper breakdown → | 2004 | 1062 |
| 3 | 2008 | 169 | |
| 4 | 2008 | 164 | |
| 5 | 2007 | 157 | |
| 6 | 2010 | 146 | |
| 7 | 1995 | 103 | |
| 8 | 2011 | 86 | |
| 9 | 2011 | 83 | |
| 10 | 2003 | 82 | |
| 11 | 2011 | 81 | |
| 12 | 2015 | 70 | |
| 13 | 2016 | 52 | |
| 14 | 2001 | 48 | |
| 15 | 2012 | 38 | |
| 16 | 1981 | 30 | |
| 17 | 2005 | 24 | |
| 18 | 2020 | 12 | |
| 19 | 2010 | 6 | |
| 20 | 2010 | 5 |
About Sharon Barr
Sharon Barr is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Genetics, having authored 27 papers that have together received 3.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (10 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related Molecular Pathways (2 papers), Fungal Plant Pathogen Control (2 papers), HER2/EGFR in Cancer Research (2 papers), RNA Research and Splicing (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Genetics (1.4k citations), Biomaterials (467 citations), Cancer Research (432 citations), Molecular Biology (1.7k citations) and Surgery (950 citations). Sharon Barr has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Eugenio Stabile, Stephen E. Epstein, Mary Susan Burnett, Timothy Kinnaird, Sabine Fuchs, Tim Kinnaird, Shmuel Fuchs, Magang Shou, Edward M. Johnson and Elizabeth Buck. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Blood, Biochemical and Biophysical Research Communications and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.